Over the last 30 years, the prognosis for children and young adults with osteosarcoma has
changed dramatically. Whereas once fewer than 20% of patients were cured by surgery …

Objective: The purpose of this article is to present 14 cases of osteosarcoma of the jaw
treated at our medical center from 1989 to 1998. These cases are discussed in the light of a …

BACKGROUND: The current study was performed to evaluate outcomes in patients with
osteosarcoma of the head and neck (OHN) who were treated with surgery with or without …

BACKGROUND The current study reviews the authors' recent institutional experience in the
treatment of osteosarcoma of the head and neck (OSHN). METHODS The clinical records of …

BACKGROUND: Osteosarcomas (OS) of all sites account for approximately 40% to 60% of
primary malignant bone tumors. About 10% of OS occur in the head and neck; most are …

BACKGROUND Primary osteosarcomas of the head and neck in the pediatric age group, not
associated with previous irradiation or a known syndrome, are rare. The literature contains …

The aim of this retrospective analysis was to evaluate patient and tumor characteristics and
treatment results and prognostic factors for patients with craniofacial osteosarcoma (CFOS) …

Maxillofacial osteosarcoma (MFOS) is a rare disease that presents and behaves differently
to the more commonly seen osteosarcoma (OS) of long bones. Neoadjuvant chemotherapy …

Background There is an ongoing debate about the value of (neo‐) adjuvant chemotherapy
in high‐and intermediate‐grade osteosarcoma of the head and neck. Methods All records of …

The aim of this study was to analyze the clinicopathological features and
immunohistochemical expression of p53, MDM2, CDK4, PCNA and Ki67 proteins in 25 head …